Inflammatory markers and cardiometabolic diseases

Area of Science:

• Cardiovascular Science
• Metabolic Science
• Inflammation Research

Background:

• Obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease are increasingly linked to chronic inflammation.
• Inflammation plays a critical role in the pathophysiology of cardiometabolic disorders.

Purpose of the Study:

• To review recent literature on the pathological implications of inflammation in obese patients with cardiometabolic disorders.
• To explore the therapeutic potential of targeting inflammation in these conditions.

Main Methods:

• A narrative review of current scientific literature.
• Focus on data describing inflammation's role in obese patients with cardiometabolic conditions.

Main Results:

• Various inflammatory markers are identified in key organs, beyond high-sensitive C-reactive protein.
• Targeting inflammation reduces systemic inflammatory markers, improves insulin sensitivity, and enhances glucose control.
• These interventions may reduce the risk of cardiovascular complications.

Conclusions:

• Inflammation is confirmed as a key factor in cardiometabolic diseases.
• Pharmacological strategies targeting inflammation are supported, particularly for type 2 diabetes management.